Literature DB >> 18159442

The management of infection and colonization due to methicillin-resistant Staphylococcus aureus: A CIDS/CAMM position paper.

Andrew E Simor1, Mark Loeb.   

Abstract

Methicillin-resistant Staphylococcus aureus (MRSA) is being seen with greater frequency in most hospitals and other health care facilities across Canada. The organism may cause life-threatening infections and has been associated with institutional outbreaks. Several studies have confirmed that MRSA infection is associated with increased morbidity and mortality compared with infections caused by susceptible strains, even when the presence of comorbidities is accounted for. Treatment of MRSA infection is complicated by the fact that these organisms are resistant to multiple antimicrobial agents, so treatment options are limited. The effectiveness of decolonization therapy (attempting to eradicate MRSA carriage) is also uncertain. This paper reviews the medical management of MRSA infections, discusses the potential role of decolonization and provides an overview of evidence to support recommended infection control practices.

Entities:  

Keywords:  MRSA; Methicillin resistance; Staphylococcus aureus

Year:  2004        PMID： 18159442      PMCID： PMC2094920          DOI： 10.1155/2004/531434

Source DB:  PubMed          Journal:  Can J Infect Dis        ISSN： 1180-2332


  126 in total

1.  Rapid development of ciprofloxacin resistance in methicillin-susceptible and -resistant Staphylococcus aureus.

Authors:  H M Blumberg; D Rimland; D J Carroll; P Terry; I K Wachsmuth
Journal:  J Infect Dis       Date:  1991-06       Impact factor: 5.226

2.  In vitro Gram-positive antimicrobial activity of evernimicin (SCH 27899), a novel oligosaccharide, compared with other antimicrobials: a multicentre international trial.

Authors:  R N Jones; R S Hare; F J Sabatelli
Journal:  J Antimicrob Chemother       Date:  2001-01       Impact factor: 5.790

3.  Interaction between vancomycin and rifampin against Staphylococcus aureus.

Authors:  C Watanakunakorn; J C Guerriero
Journal:  Antimicrob Agents Chemother       Date:  1981-06       Impact factor: 5.191

4.  Methicillin-resistant, quinupristin-dalfopristin-resistant Staphylococcus aureus with reduced sensitivity to glycopeptides.

Authors:  G Werner; C Cuny; F J Schmitz; W Witte
Journal:  J Clin Microbiol       Date:  2001-10       Impact factor: 5.948

5.  Linezolid (PNU-100766) versus vancomycin in the treatment of hospitalized patients with nosocomial pneumonia: a randomized, double-blind, multicenter study.

Authors:  E Rubinstein; S Cammarata; T Oliphant; R Wunderink
Journal:  Clin Infect Dis       Date:  2001-01-26       Impact factor: 9.079

6.  Nosocomial Staphylococcus aureus bacteremia among nasal carriers of methicillin-resistant and methicillin-susceptible strains.

Authors:  M Pujol; C Peña; R Pallares; J Ariza; J Ayats; M A Dominguez; F Gudiol
Journal:  Am J Med       Date:  1996-05       Impact factor: 4.965

7.  Eradication of colonization by methicillin-resistant Staphylococcus aureus by using oral minocycline-rifampin and topical mupirocin.

Authors:  R Darouiche; C Wright; R Hamill; M Koza; D Lewis; J Markowski
Journal:  Antimicrob Agents Chemother       Date:  1991-08       Impact factor: 5.191

8.  Control of methicillin-resistant Staphylococcus aureus at a university hospital: one decade later.

Authors:  J A Jernigan; M A Clemence; G A Stott; M G Titus; C H Alexander; C M Palumbo; B M Farr
Journal:  Infect Control Hosp Epidemiol       Date:  1995-12       Impact factor: 3.254

9.  Methicillin-resistant Staphylococcus aureus in tertiary care institutions on the Canadian prairies 1990-1992.

Authors:  J Embil; K Ramotar; L Romance; M Alfa; J Conly; S Cronk; G Taylor; B Sutherland; T Louie; E Henderson
Journal:  Infect Control Hosp Epidemiol       Date:  1994-10       Impact factor: 3.254

10.  Trimethoprim-sulfamethoxazole compared with vancomycin for the treatment of Staphylococcus aureus infection.

Authors:  N Markowitz; E L Quinn; L D Saravolatz
Journal:  Ann Intern Med       Date:  1992-09-01       Impact factor: 25.391
View more
  12 in total

1.  Pharmacokinetic-pharmacodynamic evaluation of daptomycin, tigecycline, and linezolid versus vancomycin for the treatment of MRSA infections in four western European countries.

Authors:  A Canut; A Isla; C Betriu; A R Gascón
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-02-28       Impact factor: 3.267

2.  Methicillin-resistant Staphylococcus aureus in First Nations communities in Canada.

Authors: 
Journal:  Paediatr Child Health       Date:  2005-11       Impact factor: 2.253

3.  [Not Available].

Authors: 
Journal:  Paediatr Child Health       Date:  2005-11       Impact factor: 2.253

4.  Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective.

Authors:  Marcie Tomblyn; Tom Chiller; Hermann Einsele; Ronald Gress; Kent Sepkowitz; Jan Storek; John R Wingard; Jo-Anne H Young; Michael J Boeckh; Michael A Boeckh
Journal:  Biol Blood Marrow Transplant       Date:  2009-10       Impact factor: 5.742

Review 5.  Economic features of antibiotic resistance: the case of methicillin-resistant Staphylococcus aureus.

Authors:  Fernando Antonanzas; Carmen Lozano; Carmen Torres
Journal:  Pharmacoeconomics       Date:  2015-04       Impact factor: 4.981

6.  Methicillin-resistant Staphylococcus aureus: A public health issue with economic consequences.

Authors:  Mireille Goetghebeur; Pierre-Alexandre Landry; Donald Han; Colin Vicente
Journal:  Can J Infect Dis Med Microbiol       Date:  2007-01       Impact factor: 2.471

7.  The anti-MRSA compound 3-O-alpha-L-(2″,3″-di-p-coumaroyl)rhamnoside (KCR) inhibits protein synthesis in Staphylococcus aureus.

Authors:  Nicholas J Carruthers; Paul M Stemmer; Joe Media; Ken Swartz; Xiaojuan Wang; Nicholas Aube; Mark T Hamann; Frederick Valeriote; Jiajiu Shaw
Journal:  J Proteomics       Date:  2019-10-17       Impact factor: 4.044

8.  Clinical practice guidelines for hospital-acquired pneumonia and ventilator-associated pneumonia in adults.

Authors:  Coleman Rotstein; Gerald Evans; Abraham Born; Ronald Grossman; R Bruce Light; Sheldon Magder; Barrie McTaggart; Karl Weiss; George G Zhanel
Journal:  Can J Infect Dis Med Microbiol       Date:  2008-01       Impact factor: 2.471

9.  Survey of policy for MRSA screening in English cataract surgical units and changes to practice after updated National guidelines.

Authors:  Lavnish Joshi; Stephanie K West; Luke Herbert
Journal:  BMC Ophthalmol       Date:  2013-12-17       Impact factor: 2.209

10.  Factors associated with bacteraemia due to multidrug-resistant organisms among bacteraemic patients with multidrug-resistant organism carriage: a case control study.

Authors:  Hélène Mascitti; Clara Duran; Elisabeth-Marie Nemo; Frédérique Bouchand; Ruxandra Câlin; Alexis Descatha; Jean-Louis Gaillard; Christine Lawrence; Benjamin Davido; François Barbier; Aurélien Dinh
Journal:  Antimicrob Resist Infect Control       Date:  2018-09-29       Impact factor: 4.887
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.